FDA has approved a second vaccine for mpox as cases in the ongoing outbreak continue to expand from central Africa to other regions, with the manufacturer of the new option pledging to donate doses, but it’s not clear whether the shot will be affordable in the nations most impacted. Emergent BioSolutions announced Thursday (Aug. 29) FDA has approved a supplemental biologics license application expanding indications for its vaccine ACAM2000 to include prevention of mpox disease in individuals determined to be...